Sebastien Martinez
Mount Sinai Hospital
Toronto, ON, Canada
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Author Correction: In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.
Journal: Nature communications
Published: September 05, 2023
In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer.
Journal: Nature communications
Published: December 06, 2022
Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.
Journal: Molecular systems biology
Published: September 12, 2022
CD9 mediates the uptake of extracellular vesicles from cancer-associated fibroblasts that promote pancreatic cancer cell aggressiveness.
Journal: Science signaling
Published: August 02, 2022
In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer.
Journal: Nature communications
Published: May 06, 2022
Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 19, 2022
The GATOR-Rag GTPase pathway inhibits mTORC1 activation by lysosome-derived amino acids.
Journal: Science (New York, N.Y.)
Published: August 10, 2019
Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness.
Journal: The Journal of clinical investigation
Published: April 05, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026